Antisense oligonucleotides provide optimism to the therapeutic landscape for tauopathies

被引：0
|
作者：
Glenn A.Harris [1 ]
Lauren R.Hirschfeld [1 ]
机构：
[1] Rainwater Charitable Foundation
来源：
NeuralRegenerationResearch | 2025年 / 20卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R741 [神经病学];
学科分类号：
摘要：
Tauopathies are a group of neurodegenerative diseases characterized by abnormal metabolism of the misfolded tau protein. Tau is encoded by the microtubule-associated protein tau gene(MAPT) and can be classified as either 3-repeat(3R) or 4-repeat(4R) based on the number of repeat domains from alternative splicing of exon 10 of the MAPT gene.
引用
收藏
页码：803 / 804
页数：2
相关论文
共 50 条
  • [41] Purification of antisense oligonucleotides
    Deshmukh, RR
    Cole, DL
    Sanghvi, YS
    ANTISENSE TECHNOLOGY, PT A: GENERAL METHODS, METHODS OF DELIVERY, AND RNA STUDIES, 2000, 313 : 203 - 226
  • [42] Pharmacology of antisense oligonucleotides
    Dean, NM
    Cooper, SR
    Shanahan, W
    Taylor, J
    Myers, K
    JOURNAL OF CLINICAL LIGAND ASSAY, 2000, 23 (01): : 43 - 49
  • [43] PHARMACOKINETICS OF ANTISENSE OLIGONUCLEOTIDES
    AGRAWAL, S
    TEMSAMANI, J
    GALBRAITH, W
    TANG, JY
    CLINICAL PHARMACOKINETICS, 1995, 28 (01) : 7 - 16
  • [44] Antisense oligonucleotides in cancer
    Castanotto, Daniela
    Stein, Cy A.
    CURRENT OPINION IN ONCOLOGY, 2014, 26 (06) : 584 - 589
  • [45] CHARACTERIZATION OF ANTISENSE OLIGONUCLEOTIDES
    AGRAWAL, S
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1994, 208 : 153 - ANYL
  • [46] Conjugated antisense oligonucleotides
    Manoharan, M
    Tivel, KL
    Condon, TP
    Andrade, LK
    BarberPeoch, I
    Inamati, G
    Shah, S
    Mohan, V
    Graham, MJ
    Bennett, CF
    Crooke, ST
    Cook, PD
    NUCLEOSIDES & NUCLEOTIDES, 1997, 16 (7-9): : 1129 - 1138
  • [47] Identification and characterization of a MAPT-targeting locked nucleic acid antisense oligonucleotide therapeutic for tauopathies
    Easton, Amy
    Jensen, Marianne L.
    Wang, Congwei
    Hagedorn, Peter H.
    Li, Yuwen
    Weed, Michael
    Meredith, Jere E.
    Guss, Valerie
    Jones, Kelli
    Gill, Martin
    Krause, Carol
    Brown, Jeffrey M.
    Hunihan, Lisa
    Natale, Joanne
    Fernandes, Alda
    Lu, Yifeng
    Polino, Joe
    Bookbinder, Mark
    Cadelina, Greg
    Benitex, Yulia
    Sane, Ramola
    Morrison, John
    Drexler, Dieter
    Mercer, Stephen E.
    Bon, Charlotte
    Pandya, Nikhil J.
    Jagasia, Ravi
    Yang, Tai-Hsien Ou
    Distler, Tania
    Grueninger, Fiona
    Meldgaard, Michael
    Terrigno, Marco
    Macor, John E.
    Albright, Charles F.
    Loy, James
    Hoeg, Anja M.
    Olson, Richard E.
    Cacace, Angela M.
    MOLECULAR THERAPY-NUCLEIC ACIDS, 2022, 29 : 625 - 642
  • [48] Antisense oligonucleotides for neurodegeneration
    Leavitt, Blair R.
    Tabrizi, Sarah J.
    SCIENCE, 2020, 367 (6485) : 1428 - 1429
  • [49] Specificity of antisense oligonucleotides
    Tidd, DM
    PERSPECTIVES IN DRUG DISCOVERY AND DESIGN, 1996, 4 : 51 - 60
  • [50] Antisense oligonucleotides for diabetes
    不详
    DIABETES OBESITY & METABOLISM, 2000, 2 (06): : 390 - 391
12345